News | February 13, 2007

100 Percent Accuracy with Newly Cleared Cardiac CT Software

Feb. 14, 2007 — Rcadia Medical Imaging, Ltd., an Israel-based developer of novel computer-aided diagnostic software, has received FDA clearance to market its COR Analyzer I, which assists screening of triage patients for coronary artery disease.

In a recent pilot study, Rcadia COR Analyzer I and COR Analyzer II packages successfully identified coronary artery disease in 100 percent of patients and 99 percent of the analyzed blood vessels.

To determine whether chest pain was caused by coronary artery disease, Rcadia's COR Analyzer products automatically reconstruct and accurately analyze patient CTA images.

"Particularly in the ER, adopting the Rcadia COR Analyzer software, which works hand-in-hand with CTA images, enables highly accurate identification of coronary artery disease as the cause for chest pain," says Dr. Anna Chacko, vice chairman of the division of radiology at Boston Medical Center.

According to a company press release, Rcadia's COR Analyzer I and COR Analyzer II computer-aided diagnostic software packages use proprietary image processing algorithms to analyze CT Angiography (CTA) studies to provide extremely fast and accurate identification of coronary artery disease.

In the U.S., more than five million patients present in the ER with acute chest pain each year. Identifying appropriate treatment causes a variety of clinical and work-flow difficulties. This is because missing clinically significant coronary artery disease can lead to morbidity, while misdiagnosing non-significant coronary artery disease leads to further, unnecessary cardiac evaluations.

"CTA is being rapidly adopted to triage patients in ERs across the U.S.,” said Dr. Chacko. “Rcadia's COR Analyzer II can quickly identify coronary artery disease with a high degree of accuracy. Thus, it streamlines patient care and prevents unnecessary delays in diagnosis and treatment."

"The real benefit of Rcadia's software is its high negative predictive (NPV) value," explains Jeff Mendel, M.D., chair, Department of Radiology at Caritas St. Elizabeth's Hospital in Boston. Dr. Mendel adds that high NPV is the key to screening because it identifies true negative tests and is highly reliable in ruling out coronary artery disease.

Regulatory notice: The COR Analyzer II is an investigational device and is not yet available for sales in the U.S.

Related Content

Hospital for Special Surgery Invests in Sectra Orthopedic 3-D Planning Software
News | Orthopedic Imaging | January 18, 2018
January 18, 2018 – International medical imaging IT and cybersecurity company Sectra announces that Hospital for Spec
Philips Introduces Technology Maximizer Program for Imaging Equipment Upgrades
Technology | Imaging | January 17, 2018
January 17, 2018 — Philips recently announced the launch of Technology Maximizer, a cross-modality program designed t
Fat Distribution in Women and Men Provides Clues to Heart Attack Risk
News | Women's Health | January 11, 2018
January 11, 2018 – It’s not the amount of fat in your body but where it is stored that may increase your risk for hea
Minimally Invasive Treatment Provides Relief from Back Pain

Lumbar spine MRI showing disc herniation and nerve root at baseline and one month after treatment

News | Interventional Radiology | January 11, 2018
The majority of patients were pain free after receiving a new image-guided pulsed radiofrequency treatment for low back...
Emergency Radiologists See Inner Toll of Opioid Use Disorders

Rates of Imaging Positivity for IV-SUDs Complications. Image courtesy of Efren J. Flores, M.D.

News | Clinical Study | January 11, 2018
January 11, 2018 – Emergency radiologists are seeing a high prevalence of patients with complications related to opio
CT Shows Enlarged Aortas in Former Pro Football Players

3-D rendering from a cardiac CT dataset demonstrating mild dilation of the ascending aorta.

News | Computed Tomography (CT) | January 11, 2018
Former National Football League (NFL) players are more likely to have enlarged aortas, a condition that may put them at...

Size comparison between 3-D printed prosthesis implant and a penny.

News | 3-D Printing | January 11, 2018
January 11, 2018 — Researchers using...
BlueCross BlueShield Companies in Eight States Issue Positive Medical Policies for HeartFlow FFRct Analysis
News | CT Angiography (CTA) | December 28, 2017
HeartFlow Inc. announced that Health Care Service Corp. (HCSC), which operates Blue Cross and Blue Shield plans in five...
Artificial intelligence was the number one topic in radiology in 2017.

Artificial intelligence was the number one topic of interest in radiology in 2017, based on the most popular articles and videos on ITN in 2017.

Feature | Imaging | December 28, 2017
The Imaging Technology News (ITN) website had another record year with more than 1.25 million page views in 2017.
Median Technologies Collaborating With Chinese Hospital for Lung Cancer Screening Programs. Dave Fornell
News | Lung Cancer | December 22, 2017
Median Technologies recently announced a research collaboration agreement with Xingtai People's Hospital, Xingtai City...
Overlay Init